Develops drugs for Tourette Syndrome and Alzheimer's disease.
Dec 2024Revenue $1.31M/yrExpenses $8.62M/yr
No trendCash runway ≈ 4 months from Dec 2024
Figures by year
When will SciSparc be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2024, revenue was $1.31M and expenses $8.62M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2024 | $1.31M | $8.62M | −$7.32M |
| Dec 2023 | $2.88M | $9.69M | −$6.82M |
| Dec 2022 | $1.35M | $9.63M | −$8.29M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.